PP100219006238 |
Spexis AG (since Dec 2021), Polyphor Ltd |
POL6326 |
balixafortide |
A potent, .. |
Metastatic.. |
Phase III, Phase II, Phase II, Phase II, Early stage |
View Details
|
PP100219006240 |
Spexis AG (since Dec 2021), Polyphor Ltd |
POL6014 |
lonodelestat |
A serine p.. |
Cystic fib.. |
Phase I completed, Phase I completed, Preclinical |
View Details
|
PP090630007215 |
Synairgen plc., Synairgen Research Ltd |
SNG001 |
interferon beta 1a (IFNβ) |
Replacemen.. |
COVID-19; .. |
Phase III, Phase II, Phase I |
View Details
|
PP090520007266 |
TAIHO PHARMACEUTICAL CO., LTD. |
ABI-007 |
paclitaxel |
A microtub.. |
Pancreatic.. |
Phase III, Phase I |
View Details
|
PP090630007381 |
TauRx Pharmaceuticals Ltd. |
LMTX, LMT-X |
hydromethylthionine mesylate (HMTM); leuco-methylthioninium-bis(hydromethanesulfonate) |
A tau aggr.. |
Alzheimer'.. |
NDA, Phase III, Phase I |
View Details
|
PP110125008200 |
Soligenix, Inc. |
SGX203 |
beclomethasone 17,21-dipropionate (BDP) |
A steroid. |
Pediatric .. |
Phase II completed |
View Details
|
PP110125008202 |
Soligenix, Inc. |
RiVax |
A-chain of the ricin toxin and Aluminum |
To induce .. |
Ricin toxi.. |
Phase I completed |
View Details
|
PP110128008226 |
Stealth BioTherapeutics Inc. (since ), Stealth Peptides Inc. |
Bendavia, Ocuvia, MTP131, SS-31 |
elamipretide |
To target .. |
Barth synd.. |
NDA, Phase II, Phase II, Phase II |
View Details
|
PP110331008319 |
Targazyme, Inc. (since Dec 2013), America Stem Cell, Inc. |
TZ101, ASC-101 Hematopoietic SC |
stem cells with a recombinant enzyme, α-1,3 fucosyltransferase VI (FTVI) and its substrate, GDP-fucose. |
Fucosyltra.. |
Prevention.. |
Phase III |
View Details
|
PP121226010596 |
Soricimed Biopharma Inc. |
SOR-C13 |
|
To modulat.. |
Ovarian ca.. |
Phase I completed, Phase I completed, Phase I completed, Phase I completed |
View Details
|